4.7 Article

Fabrication of Cellulose-Nanocrystal-Based Folate Targeted Nanomedicine via Layer-by-Layer Assembly with Lysosomal pH-Controlled Drug Release into the Nucleus

Journal

BIOMACROMOLECULES
Volume 20, Issue 2, Pages 937-948

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.biomac.8b01556

Keywords

-

Funding

  1. National Natural Science Foundation of China [51573050, 81871405]

Ask authors/readers for more resources

To increase the cellular uptake and drug loading of cellulose nanocrystal (CNC)-based nanomedicines, folate/cis-aconityl-doxorubicin@polyethylenimine@CNC (FA/CAD@PEI@CNC) nanomedicines were built up by the building blocks of folate (FA), cis-aconityl-doxorubicin (CAD), polyethylenimine (PEI), and CNCs via the robust layer-by-layer (LbL) assembly technique. The drug loading content (DLC) of FA/CAD@PEI@CNC hybrids was 11.3 wt %, which was almost 20-fold higher than that of the CNC-based nano-prodrug we reported previously. FA/CAD@PEI@CNC nanomedicines showed lysosomal pH-controlled drug release profiles over 24 h. In detail, the cumulative drug release was over 95% at pH 5.5, while the cumulative drug release was only 17% at pH 7.4. In vitro, FA/CAD@PEI@CNC hybrid nanomedicines had a higher (9.7-fold) mean fluorescent intensity (MFI) than that of DOX-HCl, with enhanced cytotoxicity and decreased IC50 against MCF-7. Thus, FA/CAD@PEI@CNC hybrid nanomedicines displayed efficient targetability and enhanced cellular uptake. In addition, FA/CAD@PEI@CNC nanomedicine could deliver more DOX to the nucleus than the control group, due to the beta-carboxylic acid catalyzed breakage of the pH-labile cis-aconityl amide linkages in CAD. These results indicated that FA/CAD@PEI@CNC nanomedicines achieved lysosomal pH-controlled drug release into the nucleus and showed great potential to be high-performance nanomedicines to improve the delivery efficiency and therapy efficacy. This study for CNC-based nanomedicines provided important insights into the bioapplication of CNCs modified by LbL assembly.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Co-Prodrugs of 7-Ethyl-10-hydroxycamptothecin and Vorinostat with in Vitro Hydrolysis and Anticancer Effects

Shuangxi Liu, Zonglong Hu, Qiumeng Zhang, Qiwen Zhu, Yi Chen, Wei Lu

ACS OMEGA (2020)

Article Chemistry, Medicinal

Design and synthesis of new lenalidomide analogs via Suzuki cross-coupling reaction

Donghuai Xiao, Yu-jie Wang, Han-lin Wang, Yu-bo Zhou, Jia Li, Wei Lu, Jiyu Jin

ARCHIV DER PHARMAZIE (2020)

Article Biophysics

Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nanomicelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release

Yuliu Zhang, Yi Xiao, Yushu Huang, Yang He, Yanyun Xu, Wei Lu, Jiahui Yu

COLLOIDS AND SURFACES B-BIOINTERFACES (2020)

Article Pharmacology & Pharmacy

Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform

Yushu Huang, Wanli Zhang, Yanyun Xu, Shulei Zhu, Yanqian Wu, Tiandong Chen, Yi Xiao, Wei Lu, Xiongwen Zhang, Jiahui Yu

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Article Biophysics

Redox sensitive nano-capsules self-assembled from hyaluronic acid-hydroxychloroquine conjugates for CD44-targeted delivery of hydroxychloroquine to combat breast cancer metastasis in vitro and in vivo

Yang He, Yanyun Xu, Yushu Huang, Hao Quang, Xiaoyan Xia, Hongbo Zhao, Yi Xiao, Wei Lu, Jiahui Yu

Summary: In this study, a pH and redox dual-responsive polymer prodrug was developed for the efficient delivery of drugs to metastatic breast cancer cells, leading to inhibition of cancer metastasis to the lung. The nanocapsules showed enhanced drug release under low pH and high redox conditions, as well as active targeting and selectivity to breast cancer cells. Furthermore, the nanocapsules significantly inhibited cell migration and invasion, and suppressed lung metastasis with minimal toxicity.

COLLOIDS AND SURFACES B-BIOINTERFACES (2022)

Article Chemistry, Applied

An HSP90 inhibitor based fluorescent probe for selective tumor targeting

Shulei Zhu, Yingxin Lu, Jiyu Jin, Jiahui Yu, Wei Lu

Summary: A fluorescent probe based on an HSP90 inhibitor was synthesized in this study, showing potential for selective tumor targeting and early diagnosis.

DYES AND PIGMENTS (2021)

Article Chemistry, Medicinal

A camptothecin-based, albumin-binding prodrug enhances efficacy and safety in vivo

Zhiyang Cheng, Ying Huang, Qianqian Shen, Yangrong Zhao, Lei Wang, Jiahui Yu, Wei Lu

Summary: The study presented an albumin-based drug delivery system, synthesized an antitumor prodrug Mal-glu-CPTS0001, and demonstrated its in vivo antitumor effects. The prodrug covalently binds to plasma albumin, releases the drug in tumors, and achieves reduced toxicity and enhanced selectivity.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

SN38-based albumin-binding prodrug for efficient targeted cancer chemotherapy

Ying Huang, Lei Wang, Zhiyang Cheng, Biyu Yang, Jiahui Yu, Yi Chen, Wei Lu

Summary: The novel Mal-glu-SN38 prodrug showed selective delivery of SN38 to tumour sites and enhanced efficacy. With slower plasma clearance, increased drug exposure over time, and enhanced accumulation at the tumour site, Mal-glu-SN38 significantly delayed tumour growth after multiple doses, leading to an impressive reduction or even disappearance of tumours without observable side effects in 67% of mice.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Biochemistry & Molecular Biology

Design, Synthesis, and Evaluation of Near-Infrared Fluorescent Molecules Based on 4H-1-Benzopyran Core

Shuting Wang, Shulei Zhu, Yawen Tanzeng, Yuexing Zhang, Chuchu Li, Mingliang Ma, Wei Lu

Summary: A series of novel near-infrared fluorescent molecules were designed with a compact donor-acceptor-donor architecture, exhibiting significant variations in fluorescence intensity and viscosity sensitivity in different solvent polarities. Among them, one molecule M-3 showed a 3-fold increase in emission intensity in a high viscosity solvent system and a 4-fold increase in fluorescence intensity in the presence of proteins, demonstrating superior environmental sensitivity and potential for optical imaging probe development.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands

Yingxin Lu, Danwen Sun, Donghuai Xiao, Yingying Shao, Mingbo Su, Yubo Zhou, Jia Li, Shulei Zhu, Wei Lu

Summary: Novel CRBN-recruiting HDAC PROTACs were designed and synthesized, with 21a showing excellent activity and demonstrating the potential of the benzyl alcohol linker. These PROTACs exhibited outstanding inhibitory activity on different HDAC classes and showed better anti-proliferative activity on the MM.1S cell line.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Design, synthesis, and biological evaluation of 4-(1H-1,2,3-triazol-1-yl)benzamides as HSP90 inhibitors

Tingting He, Shulei Zhu, Wei Lu

Summary: Heat shock protein 90 (HSP90) is a promising target for anticancer drugs. In this study, a series of novel HSP90 inhibitors was synthesized and compound 6u exhibited the most potent anti-proliferative activity, particularly in Capan-1 cell line. Molecular modeling studies also confirmed the interaction mechanism between 6u and HSP90, suggesting it as a potential candidate for further research.

MOLECULAR DIVERSITY (2023)

Article Biochemistry & Molecular Biology

Synthesis of Hydantoin Androgen Receptor Antagonists and Study on Their Antagonistic Activity

Longjun Ma, Yan Zhou, Dehua Yang, Ming-Wei Wang, Wei Lu, Jiyu Jin

Summary: Hydroxymethylthiohydantoin, hydroxymethylthiohydantoin, and hydantoin, all containing a pyridine group, were synthesized to investigate their androgen receptor antagonistic activities. Among them, compounds 6a/6c/7g/19a/19b showed remarkable antagonistic activity against the androgen receptor, comparable to or even surpassing enzalutamide. Additionally, compounds 19a and 19b exhibited superior antiproliferative activity compared to enzalutamide in prostate cancer cells. These findings suggest that compound 19a holds promising potential as a novel AR antagonist.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Design, synthesis, and biological evaluation of BRD4 degraders

Mengyuan Ding, Yingying Shao, Danwen Sun, Suorina Meng, Yi Zang, Yubo Zhou, Jia Li, Wei Lu, Shulei Zhu

Summary: This study designed and synthesized a series of small molecule BRD4 PROTACs, among which 8b could effectively degrade BRD4 and has the potential for treating related diseases such as leukemia, multiple myeloma, and pulmonary fibrosis.

BIOORGANIC & MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Design, synthesis, and biological evaluation of Wee1 kinase degraders

Shulei Zhu, Jieyu Liu, Donghuai Xiao, Peipei Wang, Jingkun Ma, Xiaobei Hu, Jingfeng Fu, Yubo Zhou, Jia Li, Wei Lu

Summary: This study reports a novel Wee1 degrader based on PROTAC technology, which effectively degrades cellular Wee1 protein and has potential applications in cancer therapy.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

Hypoxia-Activated Albumin-Binding Exatecan Prodrug for Cancer Therapy

Zhiyang Cheng, Ying Huang, Pingxuan Shao, Lei Wang, Shulei Zhu, Jiahui Yu, Wei Lu

Summary: Stimulus-responsive albumin-based prodrugs offer a promising drug delivery strategy for targeted and controlled release in tumor microenvironments, with hypoxia-activated Mal-azoExatecan showing potential for specific tumor targeting and release control.

ACS OMEGA (2022)

No Data Available